+++
title = "SOBRsafe Inc. Reports Stellar 92.3% Revenue Growth in Q2 2025 Driven by SOBRsure(TM) GEN 2 Sales"
date = "2025-08-08T14:45:25Z"
draft = false
summary = "SOBRsafe Inc. showcases significant financial and operational growth in Q2 2025, highlighting the increasing demand for its innovative alcohol monitoring technology."
description = "SOBRsafe announces a 92.3% revenue increase in Q2 2025, driven by its innovative alcohol detection technology. Learn more about their growth and impact."
source_link = "https://rss.investorbrandnetwork.com/iw/investornewsbreaks-sobrsafe-inc-nasdaq-sobr-posts-92-year-over-year-revenue-growth-in-q2-2025-on-strong-sobrsuretm-gen-2-sales/"
enclosure = "https://cdn.newsramp.app/genai/images/258/8/c1b9a8fca00dcf48307fa8ce151bdd73.png"
article_id = 143683
feed_item_id = 18375
qrcode = "https://cdn.newsramp.app/ibn/qrcode/258/8/noteWHIF.webp"
source = "InvestorBrandNetwork (IBN)"
+++

<p>SOBRsafe Inc. (NASDAQ: SOBR), a leader in advanced alcohol monitoring and detection technology, has announced a 92.3% year-over-year revenue growth for the second quarter of 2025, achieving $104,200 in revenue. This impressive growth is largely due to the strong sales performance of its SOBRsure(TM) GEN 2 hardware and software, which made up 76.5% of the total revenue. The company also reported a notable improvement in gross margin, which rose by 380 basis points to 57.5%, alongside a reduction in net loss to $2.0 million from $2.1 million in the same quarter the previous year.</p><p>Operational milestones for SOBRsafe in Q2 2025 included the shipment of 178 SOBRsure(TM) GEN 2 devices, marking a 35.9% increase from the first quarter. The company also experienced a 109.6% year-over-year growth in annual recurring software subscription revenue, now accounting for 55.2% of the quarterly revenue. Key achievements during the quarter were the independent third-party validation of the SOBRsure(TM) GEN 2 performance, the introduction of an upgraded B2B e-commerce platform, and the granting of a European Patent for SOBRcheck(TM). Additionally, SOBRsafe expanded its sales force and ventured into the Family Law market, demonstrating its dedication to expanding its market presence.</p><p>Financially, SOBRsafe ended the quarter with $8.5 million in cash and equivalents, highlighting the company's robust financial health and its ability to support ongoing growth strategies. SOBRsafe's pioneering transdermal technology, which offers a non-invasive method for alcohol detection, sets it apart in the behavioral health, family law, and consumer sectors. For further details on SOBRsafe's innovative solutions and financial achievements, visit <a href='https://www.sobrsafe.com' rel='nofollow' target='_blank'>https://www.sobrsafe.com</a>.</p>